These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2528586)

  • 1. Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.
    Kurata A; Palker TJ; Streilein RD; Scearce RM; Haynes BF; Berzofsky JA
    J Immunol; 1989 Sep; 143(6):2024-30. PubMed ID: 2528586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
    Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antigenic sites of the envelope glycoprotein of the Iranian isolate of human T-cell leukemia virus type 1 with different subtypes of the virus.
    Mohabatkar H; Sadeghi S
    Saudi Med J; 2006 Aug; 27(8):1121-4. PubMed ID: 16883437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.
    Berzofsky JA; Pendleton CD; Clerici M; Ahlers J; Lucey DR; Putney SD; Shearer GM
    J Clin Invest; 1991 Sep; 88(3):876-84. PubMed ID: 1715888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    Peterson LB; Wilner GD; Thomas DW
    J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
    Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
    J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
    Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
    J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunodominant epitopes of human T-lymphotropic virus type 1 (HTLV-I) using synthetic peptides.
    Lairmore MD; Lal RB; Kaumaya PT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):117-22. PubMed ID: 9346842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
    Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of immunodominance in T-cell recognition, with applications to vaccine design.
    Berzofsky JA
    Princess Takamatsu Symp; 1988; 19():161-77. PubMed ID: 2479631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus.
    Roehrig JT; Risi PA; Brubaker JR; Hunt AR; Beaty BJ; Trent DW; Mathews JH
    Virology; 1994 Jan; 198(1):31-8. PubMed ID: 7505071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
    Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of HIV synthetic peptides in a natural infection.
    Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
    J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan.
    Nishimura M; Jacobson S; Uchiyama T; Ohta M; Saida T
    Mult Scler; 1996 Feb; 1(4):200-3. PubMed ID: 9345434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.